These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36532004)

  • 1. Posttransplant
    Wang L; Ji K; Chen L; Li Y; Zhu W; Yuan X; Bao X; Wu X; He J
    Front Immunol; 2022; 13():1047200. PubMed ID: 36532004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective comparative study of haplotype hematopoietic stem cell transplantation and human leukocyte antigen-matched sibling donor hematopoietic stem cell transplantation in the treatment of acute B-lymphocyte leukemia].
    Wang ZD; Sun YQ; Yan CH; Wang FR; Mo XD; Lyu M; Zhao XS; Han W; Chen H; Chen YY; Wang Y; Xu LP; Wang YZ; Liu YR; Cheng YF; Zhang XH; Liu KY; Huang XJ; Chang YJ
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):221-228. PubMed ID: 35405780
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
    Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
    Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
    Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical Significance of Serum Immunoglobulin Level after Peri- pheral Blood Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies].
    Lin T; Fang S; Wang FY; Gu ZY; Gao XN; Li F; Li M; Huang WR; Liu DH; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1774-1781. PubMed ID: 33067989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Analysis of Efficacy and Prognosis in 300 Cases of Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation].
    Zhang Y; Song ZY; Li YH; Lu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1979-1985. PubMed ID: 31839070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor.
    Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1655-1662. PubMed ID: 32504861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
    Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant.
    Zhu J; Wang Q; Liu Y; Dong Y; Liang Z; Yin Y; Liu W; Xu W; Sun Y; Wang B; Wang Q; Wang Q; Han N; Ren H; Li Y
    Int Immunopharmacol; 2023 Jul; 120():110299. PubMed ID: 37201405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.
    Li H; Li X; Chen Y; Li D; Chen X; Zhu Z; Wang Y; Huang J; Chen P; Chen Y; Li N
    Front Immunol; 2021; 12():733326. PubMed ID: 34804017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two Kinds of HLA-mismatched Allogeneic Hematopoictic Stem Cell Transplantation for Treatment of Hematologic Malignancies].
    Li WD; Gao ZY; Yu XJ; Lu DY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):562-7. PubMed ID: 27151030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
    Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M
    Front Immunol; 2023; 14():1165759. PubMed ID: 37304258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
    Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
    J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.
    Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D
    Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantation.
    Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
    Pediatr Transplant; 2020 Nov; 24(7):e13793. PubMed ID: 32741088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study.
    Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D
    Front Immunol; 2022; 13():912917. PubMed ID: 35812409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.